A single administration of the new lithium compound with prolonged action formed on the basis of lithium oxyburate produces an antiblepharoptosis effect in rats with reserpine depression for 24 to 48 h. It optimally prevents the development of "reserpine-desynchronization" in rats when prescribed in the morning at intervals of 48 h.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
lithium compound
8
compound prolonged
8
prolonged action
8
[efficacy lithium
4
action "reserpine
4
"reserpine depression"]
4
depression"] single
4
single administration
4
administration lithium
4
action formed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!